logo

For the Inventor, By the Inventor

Athlone, Ireland

Elan Pharma International Limited


USPTO Granted Patents = 80

% Expired Patents = 27.5



Trademarks = 12

Forward Citations = 5,653

Loading Chart...
Loading Chart...

112 inventors (with patents filed for the assignee):

goldMedal Gilad Lavi (15 out of 45 patents)

silverMedal Stephen B Ruddy (15 out of 31 patents)

bronzeMedal H William Bosch (13 out of 42 patents)

4.  Izrail Tsals (13 out of 35 patents)

5.  Joseph Gross (12 out of 77 patents)

6.  Eugene Rex Cooper (11 out of 49 patents)

7.  Gil Yigal (10 out of 35 patents)

8.  Gary G Liversidge (10 out of 29 patents)

9.  Niels Peter Ryde (10 out of 20 patents)

10.  Rajeev A Jain (8 out of 13 patents)

11.  David A Czekai (8 out of 8 patents)

12.  Tuula Ryde (7 out of 15 patents)

13.  Robert G Reed (7 out of 10 patents)

14.  Rakesh A Patel (6 out of 8 patents)

15.  Evan E Gustow (5 out of 7 patents)


Core Competencies:
Nanoparticulate Formulations
Drug Delivery Systems
Bioadhesive Compositions
Controlled Release
Nanocrystalline Formulations
Injectable Formulations
Active Agent Compositions
Therapeutics for Parkinson's
Abuse-Resistant Compositions
Antibody Screening
Scar Management
Milling Methods

80 patents:

1. 9351902 - Method and device for scar management (2016-05-31),
2. 9315571 - Specific binding members for NGF (2016-04-19),
3. 8623412 - Abuse-resistant pharmaceutical compositions (2014-01-07),
4. 8148089 - Alpha-synuclein kinase (2012-04-03),
5. 8062839 - Parkin substrate and assay (2011-11-22),
6. 8017348 - Assay for Parkinson's Disease therapeutics (2011-09-13),
7. 8003127 - Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof (2011-08-23),
8. 7998507 - Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors (2011-08-16),
9. 7998117 - Drug delivery device (2011-08-16),
10. 7931917 - Nanoparticulate fibrate formulations (2011-04-26),
11. 7927627 - Nanoparticulate fibrate formulations (2011-04-19),
12. 7910577 - Injectable nanoparticulate olanzapine formulations (2011-03-22),
13. 7879360 - Nanoparticulate compositions having a peptide as a surface stabilizer (2011-02-01),
14. 7850995 - Bioadhesive nanoparticulate compositions having cationic surface stabilizers (2010-12-14),
15. 7842232 - Sterilization of dispersions of nanoparticulate active agents with gamma radiation (2010-11-30),
Company Overview
Elan Pharma International Limited, based in Athlone, Ireland, specializes in the development and manufacturing of advanced nanoparticulate drug delivery systems. The company focuses on innovative formulations that enhance the bioavailability and therapeutic efficacy of active agents, particularly in the treatment of neurological disorders such as Parkinson's disease. Their expertise encompasses a range of technologies, including controlled release and bioadhesive compositions, aimed at improving patient outcomes through targeted and efficient drug delivery solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

80 Patents

#1 in Athlone

#40 in Ireland

#9,463 in the World

Athlone, IE
Athlone, Ireland

Elan Pharma International Limited

Forward Citations = 5,653

112 inventors:

goldMedal Gilad Lavi (15 out of 45 patents)

silverMedal Stephen B Ruddy (15 out of 31 patents)

bronzeMedal H William Bosch (13 out of 42 patents)

4.  Izrail Tsals (13 out of 35 patents)

5.  Joseph Gross (12 out of 77 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Elan Pharma International Limited. Retrieved from https://idiyas.com/company/elan-pharma-international

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…